Irene Galani - Infectious Diseases

Author Information

Irene Galani is affiliated with the Infectious Diseases Laboratory at the 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Faculty of Medicine, located in Athens, Greece. Her research primarily focuses on infectious diseases, with a significant emphasis on multidrug-resistant organisms and the mechanisms of resistance, particularly concerning Klebsiella pneumoniae and Pseudomonas aeruginosa.

Research Contributions

Irene Galani has made substantial contributions to the understanding of antimicrobial resistance, particularly in multidrug-resistant and extensively drug-resistant bacterial strains. Her work has explored novel therapeutic strategies, including various β-lactam-β-lactamase inhibitor combinations, and has provided insights into the genetic and phenotypic adaptations leading to drug resistance. Her research is crucial for developing effective treatment strategies against resistant bacterial infections, as evidenced by her studies on ceftazidime-avibactam resistance and polymyxin-resistant Klebsiella pneumoniae.

Aliases

The author is known by several aliases, including I Galani and I. Galani. However, the most complete and appropriate name used in her publications is Irene Galani.

Publication and Citation Metrics

Metric	Value
Total Citations	3791
H-index	31
Total Papers	92

Publications:

Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations

DOI: 10.1080/14787210.2021.1924674

Year: 2021

Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies

DOI: 10.1080/14787210.2021.1935237

Year: 2021

In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece.

DOI: 10.1093/jac/dkaa160

Year: 2020

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae

DOI: 10.1128/AAC.00246-20

Year: 2020

Characterization of 16S rRNA methylase genes in Enterobacterales and Pseudomonas aeruginosa in Athens Metropolitan area, 2015–2016

DOI: 10.1007/s10096-020-04006-3

Year: 2020

Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment

DOI: 10.1007/s10096-020-04000-9

Year: 2020

Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019

DOI: 10.2807/1560-7917.ES.2020.25.3.2000028

Year: 2020

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.

DOI: 10.1093/jac/dkaa503

Year: 2020

Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatment.

DOI: 10.1093/jac/dkaa245

Year: 2020

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015–2016

DOI: 10.1007/s10096-019-03517-y

Year: 2019

How Do Pathogens Enter the Host?

What is Food and Water Contamination?

What is MMR?

What are the Technological Advances in Genomic Sequencing?

Can Flaviviridae infections be prevented?

How is Schistosomiasis Diagnosed?

What are CRISPR-Cas Systems?

Which Diseases Are Transmitted by Aedes Aegypti?

What Has the Global Fund Achieved?

What role does global travel play in the spread of infectious diseases?

Partnered Content Networks

Relevant Topics